Drug Pricing and Public Value

A country is being criticized for paying less than other wealthy markets for prescription drugs. Analyze the trade-offs behind aggressive price negotiation for medicines: Who benefits, who loses, and how does this affect pharmaceutical innovation, access, and public trust? Compare at least three policy models a government could use to control drug costs while still encouraging research and ensuring patients get timely access to new treatments.